References
- https://www.pharmamanufacturing.com/articles/2020/pharmas-biggest-blockbusters/
- T. Wei, Q. Cheng, Y.-L. Min, E. N. Olson, and D. J. Siegwart, Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing, Nat. Commun., 11, 3232 (2020). https://doi.org/10.1038/s41467-020-17029-3
- A. D. Frankel and C. O. Pabo, Cellular uptake of the tat protein from human immunodeficiency virus, Cell, 55, 1189-1193 (1988). https://doi.org/10.1016/0092-8674(88)90263-2
- G. C. Kim, D. H. Cheon, and Y. Lee, Challenge to overcome current limitations of cell-penetrating peptides, BBA - Protein. Proteom., 1869, 140604 (2021). https://doi.org/10.1016/j.bbapap.2021.140604
- S. -E. Chong, D. Lee, J. H. Oh, S. Kang, S. Choi, S. H. Nam, J. Yu, H. Koo, and Y. Lee, A dimeric α-helical cell penetrating peptide mounted with HER2-selective affibody, Biomater. Sci., 2021, 9, 7826-7831 (2021).
- S. H. Nam, J. Jang, D. H. Cheon, S.-E. Chong, J. H. Ahn, S. Hyun, J. Yu, and Y. Lee, pH-activatable cell penetrating peptide dimers for potent delivery of anticancer drug to triple-negative breast cancer, J. Control. Release, 330, 898-906 (2021). https://doi.org/10.1016/j.jconrel.2020.10.063
- R. Pasqualini, E. Koivunen, E. Ruoslahti, A peptide isolated from phage display libraries is a structural and functional mimic of an RGD-binding site on integrins, J. Cell Biol., 130, 1189-1196 (1995). https://doi.org/10.1083/jcb.130.5.1189
- Y. Li, X. Zheng, M. Gong, J. Zhang, Delivery of a peptide-drug conjugate targeting the blood brain barrier improved the efficacy of paclitaxel against glioma, Oncotarget, 7, 79401-79407 (2016). https://doi.org/10.18632/oncotarget.12708
- M. Sauter, M. Strieker, C. Kleist, A. Wischnjow, V. Daniel, A. Altmann, U. Haberkorn, W. Mier, Improving antibody-based therapies by chemical engineering of antibodies with multimeric cell-penetrating peptides for elevated intracellular delivery, J. Control. Release, 322, 200-208 (2020). https://doi.org/10.1016/j.jconrel.2020.03.005
- J. Lofblom, J. Feldwisch, V. Tolmachev, J. Carlsson, S. Stahl, and F. Y. Frejd, Affibody molecules: engineered proteins for therapeutic, diagnostic and biotechnological applications, FEBS Lett., 584, 2670-2680 (2010). https://doi.org/10.1016/j.febslet.2010.04.014
- C. Eigenbrot, M. Ultsch, A. Dubnovitsky, L. Abrahmsen, and T. Hard, Structural basis for high-affinity HER2 receptor binding by an engineered protein, Proc. Natl. Acad. Sci. U. S. A., 107, 15039-15044 (2010). https://doi.org/10.1073/pnas.1005025107
- S. Jang, S. Hyun, S. Kim, S. Lee, I.-S. Lee, M. Baba, Y. Lee, and J. Yu, Cell penetrating, dimeric α-helical peptides: nanomolar inhibitors of HIV-1 transcription, Angew. Chem. Int. Ed., 53, 10086-10089 (2014). https://doi.org/10.1002/anie.201404684
- J. H. Oh, S. Nam, S. Chong, S. Hyun, S. Choi, H. Gye, S. Jang, J. Jang, S. W. Hwang, J. Yu, and Y. Lee, Multimeric amphipathic α-helical sequences for rapid and efficient intracellular protein transport at nanomolar concentrations, Adv. Sci., 5, 1800240 (2018). https://doi.org/10.1002/advs.201800240
- Y. Lin, M. M. Mazo, S. C. Skaalure, M. R. Thomas, S.R. Schultz, and M.M. Stevens, Activatable cell-biomaterial interfacing with photo-caged peptides, Chem. Sci., 10, 1158-1167 (2019). https://doi.org/10.1039/C8SC04725A
- X. X. Li, J. Chen, J. M. Shen, R. Zhuang, S. Q. Zhang, Z. Y. Zhu, and J. B. Ma, pH-Sensitive nanoparticles as smart carriers for selective intracellular drug delivery to tumor, Int. J. Pharm., 545, 274-285 (2018). https://doi.org/10.1016/j.ijpharm.2018.05.012
- S. Y. Li, H. Cheng, W. X. Qiu, L. H. Liu, S. Chen, Y. Hu, B. R. Xie, B. Li, and X. Z. Zhang, Protease-activable cell-penetrating peptide-protoporphyrin conjugate for targeted photodynamic therapy in vivo, ACS Appl. Mater. Interfaces, 7, 28319-28329 (2015). https://doi.org/10.1021/acsami.5b08637
- Y. Zhao, W. Ren, T. Zhong, S. Zhang, D. Huang, Y. Guo, X. Yao, C. Wang, W.-Q. Zhang, and X. Zhang, Tumor-specific pH-responsive peptide-modified pH-sensitive liposomes containing doxorubicin for enhancing glioma targeting and anti-tumor activity, J. Control. Release, 222, 56-66 (2016). https://doi.org/10.1016/j.jconrel.2015.12.006
- A. Komin, L. Russell, K. A. Hristova, and P. Searson, Peptide-based strategies for enhanced cell uptake, transcellular transport, and circulation: mechanisms and challenges, Adv. Drug Del. Rev., 110, 52-64 (2017). https://doi.org/10.1016/j.addr.2016.06.002